Robert B. Bazemore, President & CEO at Epizyme, Inc. (EPZM), sold 2,074 shares at $12.10 ($25K) on 2019-06-13, disclosed to the SEC on 2019-06-14.
Scheduled sale ($25k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| EPZM | SELL | 2021-02-05 | $44K | — | Filing → |
| EPZM | SELL | 2021-01-27 | $138K | — | Filing → |
| EPZM | SELL | 2020-06-30 | $154K | — | Filing → |